Association of laterality and size of perfusion lesions on neurological deficit in acute supratentorial stroke.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3310323)

Published in Int J Stroke on December 08, 2011

Authors

Meng Lee1, Jeffrey L Saver, Jeffry R Alger, Qing Hao, Noriko Salamon, Sidney Starkman, Latisha K Ali, Bruce Ovbiagele, Doojin Kim, J Pablo Villablanca, Michael T Froehler, Matthew S Tenser, David S Liebeskind

Author Affiliations

1: Stroke Center and Department of Neurology, University of California, Los Angeles, CA, USA.

Articles cited by this

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med (2008) 28.42

Measurements of acute cerebral infarction: a clinical examination scale. Stroke (1989) 14.54

Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation (2008) 4.00

Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol (1997) 2.62

Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke (2003) 2.61

Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke (1999) 2.21

Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology (1998) 2.11

Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke (1996) 1.83

Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke (1999) 1.82

Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke (1999) 1.78

Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Neurology (2009) 1.47

Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology (2008) 1.41

The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke (2006) 1.34

Advanced MR imaging of acute stroke: the University of California at Los Angeles endovascular therapy experience. Neuroimaging Clin N Am (2005) 1.24

Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke. Stroke (2009) 0.83

Articles by these authors

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 14.49

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97

Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45

The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06

Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 7.48

High-thermoelectric performance of nanostructured bismuth antimony telluride bulk alloys. Science (2008) 7.34

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81

Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke (2009) 6.62

The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia (2010) 6.23

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke (2009) 5.91

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke (2015) 5.64

Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94

Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82

Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52

Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30

Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20

Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med (2002) 3.18

DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18

Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med (2009) 3.07

Sciatica of nondisc origin and piriformis syndrome: diagnosis by magnetic resonance neurography and interventional magnetic resonance imaging with outcome study of resulting treatment. J Neurosurg Spine (2005) 3.07

Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05

Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 2.97

Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87

Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87

Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80

Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke (2010) 2.77

Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76

MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75

Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74

MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol (2005) 2.70

Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66

Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62

CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52

Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50

Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry. Stroke (2013) 2.46

Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol (2011) 2.46

Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 2.43

Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42

Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke (2004) 2.40

Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38

Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36

The smoking-thrombolysis paradox and acute ischemic stroke. Neurology (2005) 2.31

Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31

Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci (2008) 2.25

Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke (2011) 2.23

Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke (2011) 2.19

Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol (2005) 2.19

Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke (2010) 2.17

Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke (2009) 2.17

Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16

Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15

Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06

Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ (2012) 2.04

Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03

Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02

Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02